Literature DB >> 12529336

Early-stage ovarian cancer: to treat or not to treat.

Robert C Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529336     DOI: 10.1093/jnci/95.2.94

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Genome-wide identification and analysis of prognostic features in human cancers.

Authors:  Joan C Smith; Jason M Sheltzer
Journal:  Cell Rep       Date:  2022-03-29       Impact factor: 9.995

2.  Are there candidates for high-dose chemotherapy in ovarian carcinoma?

Authors:  Renaud Sabatier; Anthony Gonçalves; François Bertucci; Maria-Antonietta Capiello; Frédérique Rousseau; Eric Lambaudie; Christian Chabannon; Patrice Viens; Jean-Marc Extra
Journal:  J Exp Clin Cancer Res       Date:  2012-10-16

3.  Systematic identification of mutations and copy number alterations associated with cancer patient prognosis.

Authors:  Joan C Smith; Jason M Sheltzer
Journal:  Elife       Date:  2018-12-11       Impact factor: 8.140

4.  Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.

Authors:  Bih-Rong Wei; Shelley B Hoover; Mark M Ross; Weidong Zhou; Francesco Meani; Jennifer B Edwards; Elizabeth I Spehalski; John I Risinger; W Gregory Alvord; Octavio A Quiñones; Claudio Belluco; Luca Martella; Elio Campagnutta; Antonella Ravaggi; Ren-Ming Dai; Paul K Goldsmith; Kevin D Woolard; Sergio Pecorelli; Lance A Liotta; Emanuel F Petricoin; R Mark Simpson
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

Review 5.  Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.

Authors:  Mohammad Ezzati; Amer Abdullah; Ahmad Shariftabrizi; June Hou; Michael Kopf; Jennifer K Stedman; Robert Samuelson; Shohreh Shahabi
Journal:  Int Sch Res Notices       Date:  2014-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.